Advertisement
Advertisement
U.S. Markets close in 1 hr 25 mins
Advertisement
Advertisement
Advertisement
Advertisement

Cardiol Therapeutics Inc. (CRDL.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
2.5300-0.0500 (-1.94%)
As of 04:00PM EST. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in CAD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 12/6/2021
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.02
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 36.1900
52 Week Low 32.3200
50-Day Moving Average 33.9984
200-Day Moving Average 33.8103

Share Statistics

Avg Vol (3 month) 3368.37k
Avg Vol (10 day) 3313.18k
Shares Outstanding 542.7M
Implied Shares Outstanding 6N/A
Float 838.57M
% Held by Insiders 19.83%
% Held by Institutions 19.78%
Shares Short (Oct 14, 2021) 4479.48k
Short Ratio (Oct 14, 2021) 41.39
Short % of Float (Oct 14, 2021) 4N/A
Short % of Shares Outstanding (Oct 14, 2021) 41.12%
Shares Short (prior month Sep 14, 2021) 4245.19k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-34,975.78%

Management Effectiveness

Return on Assets (ttm)-53.66%
Return on Equity (ttm)-98.72%

Income Statement

Revenue (ttm)78.76k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -27.38M
Net Income Avi to Common (ttm)-29.54M
Diluted EPS (ttm)-0.8300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)32.72M
Total Cash Per Share (mrq)0.76
Total Debt (mrq)137.46k
Total Debt/Equity (mrq)0.41
Current Ratio (mrq)12.27
Book Value Per Share (mrq)0.50

Cash Flow Statement

Operating Cash Flow (ttm)-18.73M
Levered Free Cash Flow (ttm)-6.49M
Advertisement
Advertisement